Li, Anni
Ye, Yuxuan
Tang, Jinlin
Hu, Jiawei
Shi, Min
Wu, Yangyang
Ji, Chenbo
Zhang, Hong
Funding for this research was provided by:
National Natural Science Foundation of China (82300949)
National Natural Science Foundation of China (82170880)
the 333 High Level Talents Training Project of Jiangsu Province
the Nanjing Medical Science and Technique Development Foundation (ZKX23041)
the Science and Technology Department of Jiangsu Province (BE2023745)
the Health Commission of Jiangsu Province (H2023137)
Article History
Received: 3 March 2026
Accepted: 10 April 2026
First Online: 17 April 2026
Declarations
:
: The clinical study involving human participants was reviewed and approved by the Medical Ethics Committee of Huai’an First People’s Hospital (Approval No. YX-P-2020-041-01). The trial was registered at the Chinese Clinical Trial Registry on March 10th, 2020 (Registration No. ChiCTR2000033664). Human specimens were collected in accordance with the Declaration of Helsinki and written informed consent was obtained from all participants. The animal experiment was reviewed and approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (Approval No. IACUC-NJMU 2104014). All animal procedures were performed in accordance with relevant guidelines and regulations.
: The authors declare no competing interests.